Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Dermatology
Study Phase : Phase IV
Recipient : The Maas Clinic
Deal Size : Inapplicable
Deal Type : Inapplicable
Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
February 09, 2012
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Recipient : The Maas Clinic
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluocinonide
Therapeutic Area : Dermatology
Study Phase : Phase II
Recipient : Wake Forest University
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 10, 2011
Lead Product(s) : Fluocinonide
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Recipient : Wake Forest University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Ophthalmology
Study Phase : Phase IV
Recipient : Kenneth Beer
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Ophthalmology
Highest Development Status : Phase IV
Recipient : Kenneth Beer
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Neurology
Study Phase : Phase IV
Recipient : Beer, Kenneth R., M.D., PA
Deal Size : Inapplicable
Deal Type : Inapplicable
Upper Facial Remodeling With Perlane-L and Dysport
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
May 17, 2011
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Recipient : Beer, Kenneth R., M.D., PA
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluocinonide
Therapeutic Area : Dermatology
Study Phase : Phase IV
Recipient : Wake Forest University Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 14, 2010
Lead Product(s) : Fluocinonide
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Recipient : Wake Forest University Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Dermatology
Study Phase : Phase IV
Recipient : Wake Forest University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
January 12, 2010
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Recipient : Wake Forest University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
